MedPath

Dose Response Effect of Probiotics for the Prevention of Antibiotic-associated Diarrhea in Chinese Adults

Phase 2
Completed
Conditions
Antibiotic-associated Diarrhea
Interventions
Dietary Supplement: Probiotic
Other: Placebo
Registration Number
NCT01143623
Lead Sponsor
Changhai Hospital
Brief Summary

The purpose of this study is to determine the dose response effect of probiotic capsules for the prevention of antibiotic-associated diarrhea (AAD).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
510
Inclusion Criteria
  • age 30-70 years
  • initiating antibiotic therapy
  • informed consent
Exclusion Criteria
  • current diarrhea
  • life threatening illness
  • habitual probiotic use

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Probiotic-2Probiotic-
PlaceboPlacebo-
ProbioticProbiotic-
Primary Outcome Measures
NameTimeMethod
Incidence of antibiotic-associated diarrhea5 weeks after antibiotic discontinuation
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Changhai Hospital

🇨🇳

Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath